Receptor density as a factor governing the efficacy of the dopamine D(4) receptor ligands, L-745,870 and U-101958 at human recombinant D(4.4) receptors expressed in CHO cells

Por Gazi, L, Bobirnac, I, Danzeisen, M, Schüpbach, E, Langenegger, D, Sommer, B, Hoyer, D, Tricklebank, M, Schoeffter, P
Publicado em 1999

The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D(4.4) receptor

Por Gazi, L, Bobirnac, I, Danzeisen, M, Schüpbach, E, Bruinvels, A T, Geisse, S, Sommer, B, Hoyer, D, Tricklebank, M, Schoeffter, P
Publicado em 1998

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Por Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Illes, A, Fenaux, P, DeAngelo, D J, Stauder, R, Yee, K, Zhu, N, Lee, J-H, Valcarcel, D, MacWhannell, A, Borbenyi, Z, Gazi, L, Acharyya, S, Ide, S, Marker, M, Ottmann, O G
Publicado no Leukemia (2017)